학술논문

Serogroup A Meningococcal Conjugate Vaccine Coverage After the First National Mass Immunization Campaign -- Burkina Faso, 2011.
Document Type
Article
Source
MMWR: Morbidity & Mortality Weekly Report. 12/21/2012, Vol. 61 Issue 50, p1022-1024. 3p. 2 Charts.
Subject
*IMMUNIZATION
*ADVERTISING campaigns
*MENINGOCOCCAL vaccines
*MENINGITIS vaccines
Language
ISSN
0149-2195
Abstract
The article reports on the developments in the implementation of a national mass immunization campaign for the PsA-TT (MenAfriVac) serogroup A meningococcal conjugate vaccine in Burkina Faso. The vaccine was developed to eliminate epidemic meningitis in sub-Saharan Africa. It cites the stratified cluster survey conducted by the Burkina Faso Ministry of Health in December 2011 in cooperation with the U.S. Centers for Disease Control and Prevention (CDC) on the vaccination coverage.